Ripretinib

N-{4-Brom-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorphenyl}-N'-phenylharnstoff

Stoffgruppe

Antineoplastisches Mittel (Proteinkinase-Inhibitor)